Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Initiation of late-stage Avicine clinical trial

June 9, 1998

Genzyme Molecular Oncology and Dana-Farber agreement for fusion cell technology

June 5, 1998

Vical reports initial results from gene-based immunotherapy for prostate cancer

June 4, 1998

FDA advisory committee recommends approval of Ontak for CTCL

June 3, 1998

European Commission clears rituximab for marketing in member countries

June 3, 1998

Idec receives patent protection for radioimmunotherapy

June 3, 1998

Antisoma and Imperial Cancer Research Technology announce collaboration

May 27, 1998

Glaxo Wellcome's 3622W94: phase I trial results presented at ASCO

May 26, 1998

Pivotal trials of Allovectin-7 begin in advanced metastatic melanoma

May 26, 1998

MDX-210 shows significant antitumor activity in prostate and kidney cancer patients

May 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...